Article Top Ad

Baxter Int'l Boasts $12 Million in Eco-Savings

Baxter International, a leading global medical products and services company, says it saved $12 million through environmental initiatives in 2000. Read More

Baxter International, a leading global medical products and services company, says it saved $12 million through environmental initiatives in 2000.

According to Baxter’s 2000 Sustainability Report, the company also reduced toxic and chlorofluorocarbon air toxic air emissions by 99% per unit of production value since 1988, and plans to reduce energy consumption and associated greenhouse gases 30% per unit of production value by 2005.

“Sustainability is a key component of Baxter becoming what we call a Best Citizen. That is defining what we can do to make the world a better place at home, work and in the global community,” said Harry M. Jansen Kraemer, Jr., Baxter chairman and chief executive officer. “It’s not about being right, but about doing the right things.”

Baxter has been identified as a leader in sustainability, having been selected as the medical products industry leader for the 2000 Dow Jones Sustainability Group Index, which represents the world’s first global sustainability index tracking the performance of leading sustainability driven companies worldwide. The index consists of more than 200 companies that represent the top 10 percent of the leading sustainability companies in 64 industry groups across 36 countries. As of August 2000, the market capitalization of this index exceeded $5 trillion.

Baxter also is a pilot company for the Global Reporting Initiative (GRI) Sustainability Reporting Guidelines, which provide a global framework for sustainability reporting at the organizational level. The guidelines focus on the triple bottom line of economic, social and environmental performance. Baxter was one of the first companies to issue a sustainability report following the GRI guidelines, which were first drafted in 1999.

Baxter International Inc. is a global medical products and services company that, through its subsidiaries, provides critical therapies for people with life-threatening conditions. Baxter’s products and services in the areas of bioscience (including biopharmaceuticals, vaccines, biosurgery products and transfusion therapies), medication delivery and renal therapy are used by health-care providers and their patients in more than 100 countries.

Trellis Briefing

Subscribe to Trellis Briefing

Get real case studies, expert action steps and the latest sustainability trends in a concise morning email.
Article Sidebar 1 Ad
Article Sidebar 2 Ad